ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Abattis Bioceuticals Corporation (EM)

Abattis Bioceuticals Corporation (EM) (ATTBF)

0,000001
0,00
(0,00%)
Geschlossen 21 Juni 10:00PM

Abattis Bioceuticals Corporation (EM) (ATTBF) Aktie

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Premium

Wichtige Statistiken und Details

Current Price
0,000001
( - )
Gebot
0,00
Fragen
0,00
Volumen
160.775
0,000001 Tagesbereich 0,000001
0,000001 52-Wochen-Bereich 0,0001
Marktkapitalisierung
Handelsende
0,000001
Handelsbeginn
0,000001
Letzte Trade
775
@
1.0E-6
Letzter Handelszeitpunkt
Finanzvolumen
US$ 0
VWAP
0,000001
Durchschnittliches Volumen (3 Mio.)
US$ 48.465
Ausgegebene Aktien
476.054.139
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0
Gewinn pro Aktie (EPS)
-0,01
Erlöse (LTM)
356,88k
Nettogewinn (LTM)
-3,04M

Über Abattis Bioceuticals Corporation (EM)

Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid... Abattis Bioceuticals Corp. operates as a life sciences and biotechnology company in Canada. The company develops and licenses natural health products, medicines, extractions, and ingredients for the biological, nutraceutical, bioceutical, and cosmetic markets. It also provides Comfort, a cannabinoid enhanced nutraceutical for pain and inflammation; and Health-Canada licensed services for the cannabis industry. The company was formerly known as Abattis Biologix Corporation and changed its name to Abattis Bioceuticals Corporation in September 2012. Abattis Bioceuticals Corp. was incorporated in 1997 and is headquartered in Vancouver, Canada. Mehr anzeigen

Sektor
Healthcare
Branche
Pharmaceuticals
Website
Hauptsitz
Vancouver, Canada
Gegründet
1997
Abattis Bioceuticals Corporation (EM) is listed in the Healthcare sector of the OTC Markets with ticker ATTBF. The last closing price for Abattis Bioceuticals (EM) was US$0,00. Over the last year, Abattis Bioceuticals (EM) shares have traded in a share price range of US$ 0,000001 to US$ 0,0001.

Abattis Bioceuticals (EM) currently has 476.054.139 shares in issue. The market capitalisation of Abattis Bioceuticals (EM) is US$476,05 . Abattis Bioceuticals (EM) has a price to earnings ratio (PE ratio) of -0.00.

ATTBF Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1001.0E-61.0E-61.0E-6270691.0E-6CS
4001.0E-61.0E-61.0E-6346181.0E-6CS
12001.0E-60.00011.0E-6355661.0E-6CS
26001.0E-60.00011.0E-6769911.0E-6CS
52-9.0E-6-901.0E-50.00011.0E-6707081.18E-6CS
156001.0E-60.0001341.0E-6393481.16E-6CS
260-0.015499-99.99354838710.01550.01751.0E-6827980.00533788CS

ATTBF - Frequently Asked Questions (FAQ)

What is the current Abattis Bioceuticals Corporation (EM) share price?
The current share price of Abattis Bioceuticals Corporation (EM) is US$ 0,000001
How many Abattis Bioceuticals Corporation (EM) shares are in issue?
Abattis Bioceuticals Corporation (EM) has 476.054.139 shares in issue
What is the market cap of Abattis Bioceuticals Corporation (EM)?
The market capitalisation of Abattis Bioceuticals Corporation (EM) is USD 476,05
What is the 1 year trading range for Abattis Bioceuticals Corporation (EM) share price?
Abattis Bioceuticals Corporation (EM) has traded in the range of US$ 0,000001 to US$ 0,0001 during the past year
What is the PE ratio of Abattis Bioceuticals Corporation (EM)?
The price to earnings ratio of Abattis Bioceuticals Corporation (EM) is -0
What is the cash to sales ratio of Abattis Bioceuticals Corporation (EM)?
The cash to sales ratio of Abattis Bioceuticals Corporation (EM) is 0
What is the registered address of Abattis Bioceuticals Corporation (EM)?
The registered address for Abattis Bioceuticals Corporation (EM) is 625 Howe Street, Vancouver, British Columbia, V6C 2M6
What is the Abattis Bioceuticals Corporation (EM) website address?
The website address for Abattis Bioceuticals Corporation (EM) is www.abattis.com
Which industry sector does Abattis Bioceuticals Corporation (EM) operate in?
Abattis Bioceuticals Corporation (EM) operates in the Pharmaceuticals sector

ATTBF Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen